SLC7A11/xCT Rekombinanter Antikörper
SLC7A11/xCT Rekombinant Antikörper für IF/ICC, FC (Intra)
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IF/ICC, FC (Intra)
Konjugation
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
230227C5
Kat-Nr. : CL488-82115-2
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in IF/ICC | HeLa-Zellen |
| Erfolgreiche Detektion in FC (Intra) | HeLa-Zellen, A549-Zellen |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| Immunfluoreszenz (IF)/ICC | IF/ICC : 1:50-1:500 |
| Durchflusszytometrie (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Produktinformation
CL488-82115-2 bindet in IF/ICC, FC (Intra) SLC7A11/xCT und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | SLC7A11/xCT fusion protein Ag25431 |
| Vollständiger Name | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 |
| Berechnetes Molekulargewicht | 55 kDa |
| GenBank-Zugangsnummer | BC012087 |
| Gene symbol | SLC7A11 |
| Gene ID (NCBI) | 23657 |
| Konjugation | CoraLite® Plus 488 Fluorescent Dye |
| Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA |
| Lagerungsbedingungen | Bei -20°C lagern. Vor Licht schützen. Nach dem Versand ein Jahr stabil. Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| IF protocol for CL Plus 488 SLC7A11/xCT antibody CL488-82115-2 | Protokoll herunterladen |
| FC protocol for CL Plus 488 SLC7A11/xCT antibody CL488-82115-2 | Download protocol |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |


